Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
12.74B | 4.96B | 2.78B | 2.72B | 1.72B | Gross Profit |
7.28B | 3.92B | 2.14B | 2.04B | 1.42B | EBIT |
6.36B | 3.23B | 1.65B | 1.27B | 1.07B | EBITDA |
7.95B | 4.27B | 1.99B | 1.55B | 1.28B | Net Income Common Stockholders |
4.16B | 1.82B | 906.87M | 1.06B | 565.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.58B | 3.02B | 1.19B | 1.81B | 509.22M | Total Assets |
72.60B | 56.12B | 48.51B | 36.50B | 27.69B | Total Debt |
45.22B | 34.49B | 30.05B | 19.47B | 17.02B | Net Debt |
42.78B | 31.46B | 28.87B | 17.67B | 16.67B | Total Liabilities |
53.46B | 40.50B | 34.50B | 22.62B | 18.48B | Stockholders Equity |
19.15B | 15.62B | 14.01B | 13.88B | 9.21B |
Cash Flow | Free Cash Flow | |||
-3.24B | -4.99B | -13.43B | -7.70B | -7.68B | Operating Cash Flow |
8.60B | 3.48B | -2.43B | 219.61M | -1.68B | Investing Cash Flow |
-14.56B | -5.89B | -9.19B | -5.46B | -5.66B | Financing Cash Flow |
5.31B | 4.23B | 10.78B | 6.63B | 7.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ¥34.06B | 12.45 | 5.94% | 12.74% | 24.94% | ||
72 Outperform | ¥626.97B | 16.01 | 10.45% | 1.62% | -5.84% | -16.40% | |
71 Outperform | ¥130.26B | 9.91 | 3.01% | 8.73% | 10.23% | ||
70 Outperform | $3.94T | 11.82 | 7.23% | 2.19% | 1.72% | -33.60% | |
67 Neutral | $614.53B | 11.38 | 6.70% | ― | 3.72% | 6.31% | |
63 Neutral | ¥68.58B | 26.04 | 5.69% | -8.45% | -53.95% | ||
60 Neutral | $10.94B | 10.48 | -7.04% | 2.99% | 7.55% | -12.20% |